Signaling Pathway Of Rare Form Of Non-Hodgkin's Lymphoma Discovered
Wednesday, April 15, 2015 - 10:20
in Biology & Nature
A systematic review of the genomes of patients with ALK-negative anaplastic large cell lymphoma (ALCL), a particularly aggressive form of non-Hodgkin's lymphoma, shows that many cases of the disease are driven by alterations in the JAK/STAT3 cell signaling pathway. The study also demonstrates, in mice implanted with human-derived ALCL tumors, that the disease can be inhibited by compounds that target this pathway, raising hopes that more effective treatments might soon be developed. read more